Skip to main content
SpringerLink
Log in

Upper Urinary Tract Transitional Cell Carcinoma

  • Chapter
Urological Oncology

  • 770 Accesses

Abstract

The upper urinary tract is lined with urothelium that is identical to the urothelium lining the bladder. Like the bladder, this is exposed to the urine-borne carcinogens responsible for the development of urothelial cancers. Upper tract tumors are less common than tumors in the bladder, and this may be due to the shorter contact time of carcinogens with the urothelium or due to different activation mechanisms in the urine. Urothelial tumors of the renal pelvis account for approximately 10% of all renal tumors and 5% of all urothelial tumors (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

]References

  1. Fraley EE. Cancer of the renal pelvis. In: Skinner DG, de Kernion JB, eds. Genitourinary Cancer. Philadelphia: WB Saunders, 1978:134.

    Google Scholar 

  2. Radovanovic Z, Krajinovic, Jankovic S, et al. Family history of cancer among cases of upper urothelial tumours in the Balken nephropathy area. J Cancer Res Clin Oncol 1985;110:181–183.

    Article  CAS  PubMed  Google Scholar 

  3. Greenlee RT, Murray T, Bolden S, Wings PA. Cancer Statistics, 2000. CA Cancer J Clin 2000;50:7–33.

    Article  CAS  PubMed  Google Scholar 

  4. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, et al. Upper urinary tract tumours after primary superficial bladder tumours: prognostic factors and risk groups. J Urol 2000;164:1183–1187.

    Article  CAS  PubMed  Google Scholar 

  5. Lynch HT, Watson P Lanspa SJ, et al. Natural history of colorectal cancer in hereditary non-polyposis colorectal cancer (Lynch syndromes I and II). Dis Colon Rectum 1988;31:439–444.

    Article  CAS  PubMed  Google Scholar 

  6. Greenland JE, Weston PMT, Wallace DMA. Familial transitional cell carcinoma and the Lynch syndrome II. Br J Urol 1993;72:177–180.

    CAS  PubMed  Google Scholar 

  7. Holmang S, Johansson SL. Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcome. J Urol 2006;175:69–73.

    Article  PubMed  Google Scholar 

  8. Huben RP, Mounzer AM, Murphy GP. Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 1988;62(9):2016–2020.

    Article  CAS  PubMed  Google Scholar 

  9. Sagalowsky AI, Jarrett TW. Management of Urothelial tumors of the renal pelvis and ureter. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ, eds. Campbell’s Urology, vol 4, 8th ed. Philadelphia: WB Saunders, 2002.

    Google Scholar 

  10. Gana BM, Evans AT, Weaver JPA. Fibroepithelial polyp of the ureter. Br J Urol 1993; 72:660–661.

    Article  CAS  PubMed  Google Scholar 

  11. Park WH, Kim HG, Choi YC, et al. Upper urinary tract cholesteatoma misdiagnosed as a ureteral tumour. J Urol 2000;164:120–121.

    Article  CAS  PubMed  Google Scholar 

  12. Matsui Y, Utsunomiyya N, Ichioka K, et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 2005;65:279–283.

    Article  PubMed  Google Scholar 

  13. Kikuchi E, Horiguchi Y, Nakashima J, et al. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol 2005;174(6):2120–2123; discussion 2124.

    Article  PubMed  Google Scholar 

  14. Reitelman C, Sawczuk IS, Olsson CA, et al. Prognostic variables in patients with transitional cell carcinoma of the renal pelvis and proximal ureter. J Urol 1987; 138:1144–1145.

    CAS  PubMed  Google Scholar 

  15. Wu CF, Shee JJ, Ho DR, Chen WC, Chen CS. Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma. J Urol 2004;171: 126–129.

    Article  PubMed  Google Scholar 

  16. Khadra MH, Pickard M, Charlton PH, et al. A prospective analysis of 1,930 patients with haematuria to evaluate current diagnostic practice. J Urol 2000;163:524–527.

    Article  CAS  PubMed  Google Scholar 

  17. Matin SF. Radical laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: current status. BJU Int 2005;95(suppl 2):68–74.

    Article  PubMed  Google Scholar 

  18. Rassweiler JJ, Schulze M, Marrero R, et al. Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma: is it better than open surgery? Eur Urol 2004; 46:690–697.

    Article  PubMed  Google Scholar 

  19. Bariol SV, Stewart GD, McNeill SA, Tolley DA. Oncological control following laparoscopic nephroureterectomy: 7-year outcome. J Urol 2004;172:1805–1808.

    Article  PubMed  Google Scholar 

  20. Ho KL, Chow GK. Ureteroscopic resection of upper-tract transitional-cell carcinoma. J Endourol 2005;19:841–848.

    Article  PubMed  Google Scholar 

  21. Lam JS, Gupta M. Ureteroscopic management of upper tract transitional cell carcinoma. Urol Clin North Am 2004;31:115–128.

    Article  PubMed  Google Scholar 

  22. Treuthardt C, Danuser H, Studer UE. Tumour seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis. Eur Urol 2004; 46:442–443.

    Article  CAS  PubMed  Google Scholar 

  23. Shepherd SF, Patel A, Bidmead AM, et al. Nephrostomy track brachytherapy following percutaneous resection of transitional cell carcinoma of the renal pelvis. Clin Oncol 1995;7:385–387.

    Article  CAS  Google Scholar 

  24. Patel A, Fuchs GJ. New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper tract transitional cell carcinoma. J Urol 1998;159: 71–75.

    Article  CAS  PubMed  Google Scholar 

  25. Weston PMT, Greenland JE, Wallace DMA. Role of topical mitomycin C in upper urinary tract transitional cell carcinoma. Br J Urol 1993;71:624–625.

    Article  CAS  PubMed  Google Scholar 

  26. Thalmann GN, Markwalder R, Walter B, Studer UE. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol 2002;168:1381–1385.

    Article  PubMed  Google Scholar 

  27. Lerner SE, Blute ML, Richardson RL, Zincke H. Platinum-based chemotherapy for advanced transitional cell carcinoma of the urinary tract. Mayo Clin Proc 1996;71: 945–950.

    Article  CAS  PubMed  Google Scholar 

  28. Palou J, Piovesan LF, Huguet J, et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long term follow up. J Urol 2004;172:66–69.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Queen Elizabeth Hospital, Birmingham, UK

    D. Michael A. Wallace MBBS, FRCS

Authors
  1. D. Michael A. Wallace MBBS, FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St. Bartholomew’s and Homerton Hospitals Queen Mary Barts and the London School of Medicine and Dentistry, University of London, London, UK

    Vinod H. Nargund PhD, FRCS (Urol), FEBU (Chair, Uro-Oncology MDT and Consultant Urological Surgeon) (Chair, Uro-Oncology MDT and Consultant Urological Surgeon)

  2. Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA

    Derek Raghavan MD, PhD, FACP, FRACP (Chairman and Director) (Chairman and Director)

  3. Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA

    Howard M. Sandler MD (Professor and Senior Associate Chair) (Professor and Senior Associate Chair)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Wallace, D.M.A. (2008). Upper Urinary Tract Transitional Cell Carcinoma. In: Nargund, V.H., Raghavan, D., Sandler, H.M. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-1-84628-738-1_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-738-1_18

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-387-1

  • Online ISBN: 978-1-84628-738-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation